Celgene prepares for first European pomalidomide launches following approval
This article was originally published in Scrip
Executive Summary
Celgene's Swiss subsidiary Celgene International S�rl is gearing up to launch its multiple myeloma product pomalidomide in Germany, Austria, the Nordics, the Netherlands and the UK following final approval from the European Commission.